Suppr超能文献

通过黏膜贴片技术评估的临床和亚临床肠道炎症:炎症性肠病和肠易激综合征中黏膜中性粒细胞和嗜酸性粒细胞活化的研究。

Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.

作者信息

Kristjánsson G, Venge P, Wanders A, Lööf L, Hällgren R

机构信息

Department of Medical Sciences, University of Uppsala, University Hospital of Uppsala, 75185 Uppsala, Sweden.

出版信息

Gut. 2004 Dec;53(12):1806-12. doi: 10.1136/gut.2003.036418.

Abstract

BACKGROUND AND AIMS

There is a clear need for a rapid, simple, safe, and sensitive method of determining the type and intensity of inflammation in the gut mucosa in clinical practice. In this study, we have evaluated the potential of a new method, the mucosal patch technique, in patients with and without apparent gut inflammation, as assessed by conventional diagnostic procedures.

SUBJECTS AND METHODS

The technique tested is based on the idea that inflammatory mediators released from the rectal mucosa can be absorbed by and then extracted from cellulose patches brought into contact with the mucosa by use of an instrument with an inflatable balloon. Measurements were performed in healthy controls (n = 16) and in patients with active (n = 19) and inactive ulcerative colitis (UC, n = 8), collagen colitis (CC, n = 12), coeliac disease (n = 13), and irritable bowel syndrome (IBS, n = 13).

RESULTS

Inflammatory mediators from neutrophils (myeloperoxidase (MPO)) and eosinophils (eosinophil cationic protein (ECP)) were increased on average 300- and 10-fold, respectively, in patients with active UC compared with healthy controls and were correlated with the endoscopic score. Patients with inactive UC, CC, coeliac disease, and IBS exhibited no endoscopic signs of inflammation. These patient groups had significantly lower levels of MPO and ECP than the active UC group but showed on average a four- to sevenfold increase in MPO compared with healthy controls.

CONCLUSION

The mucosal patch technique was well tolerated by patients and easily applied by the investigator. Pronounced neutrophil and eosinophil involvement in UC was demonstrated. With the high sensitivity of the technique, low degree mucosal neutrophil activation could also be quantified in patients with CC and UC in clinical remission. The finding of increased neutrophil involvement in patients with IBS contributes to the pathophysiological ideas of this disease.

摘要

背景与目的

在临床实践中,显然需要一种快速、简便、安全且灵敏的方法来确定肠道黏膜炎症的类型和强度。在本研究中,我们评估了一种新方法——黏膜贴片技术在有或无明显肠道炎症患者中的应用潜力,这些患者通过传统诊断程序进行评估。

受试者与方法

所测试的技术基于这样一种理念,即从直肠黏膜释放的炎症介质可被与黏膜接触的纤维素贴片吸收,然后使用带有可充气气球的器械从贴片中提取出来。在健康对照者(n = 16)、活动期溃疡性结肠炎患者(n = 19)、非活动期溃疡性结肠炎患者(UC,n = 8)、胶原性结肠炎患者(CC,n = 12)、乳糜泻患者(n = 13)和肠易激综合征患者(IBS,n = 13)中进行了测量。

结果

与健康对照者相比,活动期溃疡性结肠炎患者中性粒细胞(髓过氧化物酶(MPO))和嗜酸性粒细胞(嗜酸性粒细胞阳离子蛋白(ECP))释放的炎症介质平均分别增加了300倍和l0倍,且与内镜评分相关。非活动期溃疡性结肠炎、胶原性结肠炎、乳糜泻和肠易激综合征患者无内镜下炎症表现。这些患者组的MPO和ECP水平明显低于活动期溃疡性结肠炎组,但与健康对照者相比,MPO平均升高了4至7倍。

结论

患者对黏膜贴片技术耐受性良好,研究者操作简便。证实了溃疡性结肠炎中有明显的中性粒细胞和嗜酸性粒细胞参与。由于该技术具有高敏感性,在临床缓解期的胶原性结肠炎和溃疡性结肠炎患者中也可对低度黏膜中性粒细胞活化进行量化。肠易激综合征患者中性粒细胞参与增加这一发现有助于理解该疾病的病理生理学机制。

相似文献

3
Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease.
Scand J Gastroenterol. 2005 Jun;40(6):662-9. doi: 10.1080/00365520510015566.
5
Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Scand J Gastroenterol. 2011 Jul;46(7-8):849-54. doi: 10.3109/00365521.2011.571707. Epub 2011 May 11.
7
Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
Scand J Gastroenterol. 2012 Jun;47(6):619-24. doi: 10.3109/00365521.2012.666672. Epub 2012 Apr 10.
8
Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Scand J Gastroenterol. 2006 Jan;41(1):54-9. doi: 10.1080/00365520510023909.
10
Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
Neurogastroenterol Motil. 2012 Aug;24(8):734-9, e347. doi: 10.1111/j.1365-2982.2012.01933.x. Epub 2012 May 24.

引用本文的文献

1
Elevated Fecal Biomarkers of Colo-Rectal Epithelial Cell Activity in Irritable Bowel Syndrome.
Neurogastroenterol Motil. 2025 Apr;37(4):e14984. doi: 10.1111/nmo.14984. Epub 2024 Dec 17.
6
High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.
Cell Host Microbe. 2020 Aug 12;28(2):273-284.e6. doi: 10.1016/j.chom.2020.06.001. Epub 2020 Jul 14.
7
Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.
Tech Coloproctol. 2018 Dec;22(12):941-946. doi: 10.1007/s10151-018-1896-9. Epub 2018 Dec 10.
8
Assessment of eosinophils in gastrointestinal inflammatory disease of dogs.
J Vet Intern Med. 2018 Nov;32(6):1911-1917. doi: 10.1111/jvim.15310. Epub 2018 Oct 7.
10
Current insights into the innate immune system dysfunction in irritable bowel syndrome.
Ann Gastroenterol. 2018 Mar-Apr;31(2):171-187. doi: 10.20524/aog.2018.0229. Epub 2018 Jan 18.

本文引用的文献

1
Monitoring the allergic inflammation.
Allergy. 2004 Jan;59(1):26-32. doi: 10.1046/j.1398-9995.2003.00386.x.
2
VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.
Br Med J. 1964 Jan 11;1(5375):89-92. doi: 10.1136/bmj.1.5375.89.
4
Activation of the mucosal immune system in irritable bowel syndrome.
Gastroenterology. 2002 Jun;122(7):1778-83. doi: 10.1053/gast.2002.33579.
6
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis.
Dig Dis Sci. 2001 Apr;46(4):888-97. doi: 10.1023/a:1010781224158.
9
Increased mast cells in the irritable bowel syndrome.
Neurogastroenterol Motil. 2000 Oct;12(5):449-57. doi: 10.1046/j.1365-2982.2000.00221.x.
10
A simple method for assessing intestinal inflammation in Crohn's disease.
Gut. 2000 Oct;47(4):506-13. doi: 10.1136/gut.47.4.506.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验